Offerings // PharmaCyte Biotech, Inc.

PMCB offering history

Every offering-related filing in PharmaCyte Biotech, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 470 filings back to Aug 20, 2001.

Last executed offering

Aug 18, 2025

8-K — priced deal (shares or notes)

Last registration (announced)

Sep 17, 2025

S-3 — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Sep 26, 2025	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 17, 2025	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 18, 2025	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Sep 29, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 21, 2023	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Sep 12, 2023	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Aug 4, 2023	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Jun 9, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 11, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Nov 22, 2021	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Nov 17, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 8, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Aug 23, 2021	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Aug 23, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 19, 2021	S-3MEF →	REGISTERED	S-3MEF registration — capacity to sell shares, not a sale yet
Aug 10, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 2, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 14, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Apr 5, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jan 21, 2020	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Feb 22, 2018	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Sep 28, 2017	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Sep 28, 2017	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Sep 13, 2017	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jan 12, 2016	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Dec 2, 2014	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 12, 2014	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 29, 2014	424B2 →	EXECUTED	Prospectus supplement priced — shares or notes (large filers: often a bond deal)
Oct 28, 2014	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 24, 2014	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Oct 17, 2014	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Feb 19, 2014	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Jun 28, 2012	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 1, 2009	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Mar 4, 2009	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Nov 3, 2004	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital

PMCB offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full PMCB workspace →

PMCB offering FAQ

When did PMCB last execute an offering?

Per SEC filings, PharmaCyte Biotech, Inc.'s most recent priced offering document is a 8-K filed 2025-08-18. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did PMCB last announce or register an offering?

The most recent registration is a S-3 filed 2025-09-17. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.